DAVID MEE: Open Payments
NPI 1578872099 · NORTH DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,098 in 140 payments from 14 companies in 2025. Trend: 2023 $2,124 · 2024 $2,453 · 2025 $2,098
Food & beverage: $2,019Education: $79
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 68 | $532 |
| Janssen Biotech, Inc. | 24 | $347 |
| GENZYME CORPORATION | 8 | $262 |
| Novartis Pharmaceuticals Corporation | 6 | $173 |
| UCB, Inc. | 8 | $168 |
| E.R. Squibb & Sons, L.L.C. | 5 | $114 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| Galderma Laboratories, L.P. | 3 | $87 |
| LEO Pharma Inc. | 3 | $83 |
| Amgen Inc. | 3 | $77 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Bimzelx, RINVOQ, Sotyktu, Otezla, COSENTYX.
Industry payments across MA — which companies pay providers there.
